Metabolic Stability Assays

Predict Metabolic Clearance Before In Vivo Studies

Poor metabolic stability can lead to high clearance, short half-life, and inadequate drug exposure. Metabolic stability assays evaluate how quickly a compound is metabolized using in vitro systems such as liver microsomes, hepatocytes, and S9 fractions, generating data that support lead optimization, pharmacokinetic prediction, species selection, and candidate selection. At WuXi Biology and Testing, our integrated DMPK platform provides metabolic stability assessment across multiple species and therapeutic modalities to accelerate drug discovery and development.

300K+

In Vitro ADME Studies Annually

20K+

In Vivo Studies Annually

1,500+

Successful IND Filings

Why Is Metabolic Stability Important?

Optimizing metabolic stability improves the likelihood that a drug candidate will achieve sufficient systemic exposure while maintaining an appropriate dosing profile. Understanding metabolic stability early in discovery helps identify compounds with appropriate pharmacokinetic properties before investing in expensive animal studies.

Metabolic stability studies can help researchers:

  • Estimate intrinsic clearance
  • Predict hepatic clearance
  • Compare compound series during lead optimization
  • Support IVIVE and PBPK modeling
  • Select appropriate preclinical species
  • Prioritize compounds for in vivo PK studies
  • Investigate metabolism-related structure-activity relationships (SAR)

For many discovery programs, metabolic stability serves as one of the first ADME filters before in vivo pharmacokinetic evaluation.

Choose the Right In Vitro Metabolic Stability Model

No single in vitro model answers every metabolism question. Selecting the appropriate biological system depends on the stage of drug discovery, the metabolic pathways of interest, and the intended application of the data. Selecting the appropriate model improves data interpretation and supports more informed development decisions.

Liver Microsomes

Best for evaluating CYP-mediated Phase I metabolism.

Applications:

  • Intrinsic clearance
  • CYP-dependent metabolism
  • Lead optimization
  • Species comparison

Hepatocytes

Contain both Phase I and Phase II enzymes and transporters, providing a more physiologically relevant assessment of metabolism.

Applications:

  • Overall metabolic stability
  • Metabolite identification
  • Hepatic clearance prediction
  • Drug disposition studies

S9 Fractions

Include both microsomal and cytosolic enzymes.

Applications:

  • Combined Phase I and Phase II metabolism
  • Early metabolism screening

Intestinal Microsomes

Useful for compounds undergoing first-pass intestinal metabolism.

Applications:

  • Oral drug development
  • Intestinal CYP metabolism
  • Gut wall clearance prediction

Additional systems, including liver cytosol, recombinant enzymes, and intestinal S9 fractions, are available when required to address specific metabolic questions.

Integrated Metabolic Stability Solutions Throughout Drug Discovery

Metabolic stability data become significantly more valuable when interpreted alongside other ADME assays.

Our integrated workflow combines metabolic stability with:

  • Plasma protein binding
  • CYP inhibition and induction
  • Reaction phenotyping
  • Metabolite identification
  • Plasma stability
  • Permeability assays
  • PK studies
  • PK/PD modeling

Together, these studies provide a comprehensive understanding of drug disposition and support more confident candidate selection.

Applications Across Drug Discovery

Metabolic stability assays support multiple stages of drug development.

Hit-to-Lead

  • Rank compounds
  • Eliminate rapidly metabolized molecules

Lead Optimization

  • Improve exposure
  • Understand SAR
  • Guide medicinal chemistry

Candidate Selection

  • Predict human clearance
  • Compare species
  • Support PBPK

IND-Enabling Studies

  • Support PK interpretation
  • Integrate with metabolite identification
  • Inform regulatory studies
Explore Solutions

Explore Solutions for Your Program

Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.

Get A Quote

Get a Quote

Ready to plan your next study? Share your program needs with our team for a tailored estimate.

Frequently Asked Questions

Get a Quote